Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Semaglutide scores again, this time for HFpEF in obese

Semaglutide scores again, this time for HFpEF in obese

03 Oct 2023 bởiElvira Manzano

Once weekly injection of semaglutide causes weight loss in obese patients with heart failure with preserved ejection fraction (HFpEF), with positive shifts in symptoms and improvements in physical limitations in the STEP-HFpEF trial presented at ESC 2023.

Semaglutide scores again, this time for HFpEF in obese

03 Oct 2023
Impaired renal function ups cardiovascular risk in young adults

Impaired renal function ups cardiovascular risk in young adults

01 Oct 2023
Ultraprocessed food intake ups mortality risk in T2D patients

Ultraprocessed food intake ups mortality risk in T2D patients

01 Oct 2023

Individuals with type 2 diabetes (T2D) who regularly consume ultraprocessed foods (UPF), regardless of diet quality, appear to have reduced survival and increased cardiovascular disease (CVD) mortality rate, suggests a recent study.

Ultraprocessed food intake ups mortality risk in T2D patients

01 Oct 2023
Lorundrostat may expand treatment toolbox for uncontrolled hypertension

Lorundrostat may expand treatment toolbox for uncontrolled hypertension

29 Sep 2023